EpiCept Announces Presentation of EPC2407 Data at 2008 American - MSN MoneyCentral
The authors of the poster concluded that EPC2407 studied in 17 patients is a safer and easier to use agent than previous VDA’s. The dose limiting toxicity profile of EPC2407 is consistent with its mode of action and pre-clinical studies. EPC2407
Common gene disorder doubles risk of lung cancer - HULIQ.com
Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers. The study is published in the May 26 issue of the Archives of Internal Medicine, a journal published by
Imclone’s Trading Signals Failure to Beat Avastin (Update2) - Bloomberg
May 28 (Bloomberg) — ImClone Systems Inc. ’s only drug, Erbitux, may extend life for lung cancer patients in a study scheduled for release next week. The findings may not help ImClone shares. Between August and May , ImClone rose 60 percent as
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in - Antara Interactive
The type of non-small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and, in turn, survival outcome according to the results of a major study published online in the Journal of Clinical Oncology. Publication of the
Save Write to Editor - Times of India
KOLKATA: Kolkata has upstaged Delhi as the air pollution capital of India, accounting for more deaths due to lung cancer and heart attack than the capital city. More than 18 persons per one lakh people in Kolkata fall victim to lung cancer every year